A detailed history of Janus Henderson Group PLC transactions in Agilent Technologies, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 38,726 shares of A stock, worth $5.18 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
38,726
Previous 38,726 -0.0%
Holding current value
$5.18 Million
Previous $5.02 Million 14.54%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$129.63 - $154.64 $248,630 - $296,599
-1,918 Reduced 4.72%
38,726 $5.02 Million
Q1 2024

May 15, 2024

SELL
$128.12 - $149.31 $229,719 - $267,712
-1,793 Reduced 4.23%
40,644 $5.91 Million
Q4 2023

Feb 14, 2024

SELL
$101.17 - $139.82 $1.65 Million - $2.28 Million
-16,296 Reduced 27.75%
42,437 $5.9 Million
Q3 2023

Nov 14, 2023

SELL
$109.73 - $128.47 $2.63 Million - $3.08 Million
-24,005 Reduced 29.01%
58,733 $6.57 Million
Q2 2023

Aug 14, 2023

BUY
$114.69 - $141.28 $4.21 Million - $5.19 Million
36,731 Added 79.84%
82,738 $9.95 Million
Q1 2023

May 15, 2023

SELL
$131.13 - $159.06 $17.5 Million - $21.2 Million
-133,523 Reduced 74.37%
46,007 $6.36 Million
Q4 2022

Feb 14, 2023

SELL
$125.64 - $157.68 $13.5 Million - $16.9 Million
-107,317 Reduced 37.41%
179,530 $26.9 Million
Q3 2022

Nov 14, 2022

BUY
$115.11 - $142.29 $2.91 Million - $3.6 Million
25,301 Added 9.67%
286,847 $34.9 Million
Q2 2022

Aug 15, 2022

SELL
$112.71 - $135.93 $12.9 Million - $15.5 Million
-114,098 Reduced 30.37%
261,546 $31.1 Million
Q1 2022

May 16, 2022

SELL
$126.0 - $156.48 $3.78 Million - $4.69 Million
-29,971 Reduced 7.39%
375,644 $49.7 Million
Q4 2021

Feb 14, 2022

BUY
$147.95 - $164.3 $18.9 Million - $21 Million
127,783 Added 45.99%
405,615 $64.8 Million
Q3 2021

Nov 16, 2021

SELL
$147.58 - $179.28 $10.6 Million - $12.9 Million
-71,868 Reduced 20.55%
277,832 $43.8 Million
Q2 2021

Aug 16, 2021

SELL
$127.69 - $148.81 $2.25 Million - $2.63 Million
-17,650 Reduced 4.8%
349,700 $51.7 Million
Q1 2021

May 17, 2021

BUY
$114.99 - $130.12 $1.13 Million - $1.28 Million
9,834 Added 2.75%
367,350 $46.7 Million
Q4 2020

Feb 16, 2021

SELL
$100.01 - $119.3 $6 Million - $7.16 Million
-60,002 Reduced 14.37%
357,516 $42.4 Million
Q3 2020

Nov 16, 2020

SELL
$88.11 - $103.42 $57.5 Million - $67.5 Million
-652,558 Reduced 60.98%
417,518 $42.1 Million
Q2 2020

Aug 14, 2020

BUY
$68.92 - $91.14 $33.5 Million - $44.3 Million
485,638 Added 83.09%
1,070,076 $94.6 Million
Q1 2020

May 14, 2020

SELL
$63.37 - $90.13 $2.35 Million - $3.34 Million
-37,081 Reduced 5.97%
584,438 $41.9 Million
Q4 2019

Feb 18, 2020

SELL
$72.49 - $85.45 $8.14 Million - $9.59 Million
-112,254 Reduced 15.3%
621,519 $53 Million
Q3 2019

Nov 14, 2019

SELL
$65.59 - $78.07 $3.27 Million - $3.9 Million
-49,901 Reduced 6.37%
733,773 $56.2 Million
Q2 2019

Jul 31, 2019

BUY
$66.89 - $81.94 $23.9 Million - $29.2 Million
356,601 Added 83.5%
783,674 $58.5 Million
Q1 2019

Apr 30, 2019

BUY
$63.27 - $82.0 $1.8 Million - $2.33 Million
28,454 Added 7.14%
427,073 $34.3 Million
Q4 2018

Feb 06, 2019

SELL
$61.13 - $74.67 $18.9 Million - $23.1 Million
-309,189 Reduced 43.68%
398,619 $26.9 Million
Q3 2018

Nov 09, 2018

SELL
$61.25 - $71.13 $12.9 Million - $15 Million
-211,373 Reduced 23.0%
707,808 $49.9 Million
Q2 2018

Aug 10, 2018

SELL
$61.14 - $69.55 $737,409 - $838,842
-12,061 Reduced 1.3%
919,181 $56.8 Million
Q1 2018

May 14, 2018

SELL
$65.05 - $74.82 $7.31 Million - $8.4 Million
-112,334 Reduced 10.76%
931,242 $62.3 Million
Q4 2017

Feb 09, 2018

BUY
$64.87 - $70.59 $20.3 Million - $22.1 Million
313,570 Added 42.95%
1,043,576 $69.9 Million
Q3 2017

Nov 14, 2017

SELL
$58.57 - $66.17 $6.21 Million - $7.02 Million
-106,045 Reduced 12.68%
730,006 $0
Q2 2017

Aug 17, 2017

BUY
N/A
836,051
836,051 $49.6 Million

Others Institutions Holding A

About AGILENT TECHNOLOGIES, INC.


  • Ticker A
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 296,040,992
  • Market Cap $39.6B
  • Description
  • Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatogra...
More about A
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.